Chronic progressive external ophthalmoplegia - Symptom or syndrome?;Chronisch progressive externe Ophthalmoplegie - Symptom oder Syndrom?

Klinische Monatsblatter fur Augenheilkunde

Volumn 226, Issue 10, 2009, Pages 822-828

  Bau, V ^a   Deschauer, M ^b   Zierz, S ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

CPEO; KSS; Mitochondriopathy

Indexed keywords

MITOCHONDRIAL DNA;

AUTOSOMAL DOMINANT INHERITANCE; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; GENE MUTATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; KEARNS SAYRE SYNDROME; PHENOTYPE; POINT MUTATION; PROGNOSIS; REVIEW;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; DIAGNOSIS, DIFFERENTIAL; DNA, MITOCHONDRIAL; GENES, DOMINANT; GENES, RECESSIVE; GENOTYPE; HUMANS; KEARNS-SAYRE SYNDROME; MITOCHONDRIAL MYOPATHIES; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; PHENOTYPE; POINT MUTATION; SYNDROME;

EID: 77949685737     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109800     Document Type: Review

References (35)

1. Barnard R I., Scholz R O. Ophthalmoplegia and retinal degeneration. Am J Ophthalmol 1944 27 621-624
2. Barré J A., Rohmer F. Surdité progressive, syndrome de Parinaud, troubles cérébelleux, dysreflexie vestibulaire croisée, chez un garcon de 16 ans. Troubles dégéné ratifs et ptosis chez plusieurs membres de la famille. Confin Neurol 1947 8 330-335
3. Bastiaensen L A., Joosten E MG, Rooij J AM et al. Ophthalmoplegia-plus, a real nosological entity. Acta Neurol Scand 1978 58 9-34
4. Chinnery P F., Howell N de, Lightowlers R N. et al. Molecular pathology of MELAS and MERRF. The clinical relationship between mutation load and clinical phenotypes. Brain 1997 120 1713-1721
5. Deschauer M, Hudson G, Müller T et al. A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia. Neuromuscul Disord 2005 15 311-315
6. Deschauer M, Müller T, Wieser T et al. Hearing impairment is common in various phenotypes of mitochondrial DNA A 3243G mutation. Arch Neurol 2001 58 1885-1888
7. Deschauer M, Tennant S, Rokicka A et al. MELAS associated with mutations in the POLG1 gene. Neurology 2007 68 1741-1742
8. DiMauro S, Schotland D L., Bonilla E et al. Progressive ophthalmoplegia, glycogen storage and abnormal mitochondria. Arch Neurol 1973 29 170-179
9. Fadic R, Russell J A., Vedanarayanan V V. et al. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 1997 49 239-245
10. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990 348 (6302) 651-653
11. Goto Y, Koga Y, Horai S et al. Chronic progressive external ophthalmoplegia: a correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies. J Neurol Sci 1990 100 63-69
12. Goto Y, Horai S, Matsuoka T et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992 42 545-550
13. Gowers W R. Manual diseases of the nervous system. London 1988 Volume II 184
14. Graefe A von. Verhandlungen ärztlicher Gesellschaften. Sitzung vom 19. Februar 1868 der Berliner medicinischen Gesellschaft. Berl Klin Wochenschr 1868 5 126-127
15. Hammans S R., Sweeney M G., Brockington M et al. Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet 1991 337 (8753) 1311-1313
16. (3243) mutation. Brain 1995 118 721-734
17. Hirano M, DiMauro S. ANT1, Twinkle, POLG and TP. New genes open our eyes to ophthalmoplegia. Neurology 2001 57 2163-2165
18. Hirano M. Ricci E, Koenigsberger MR et al MELAS: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992 2 125-135
19. Holt I J., Harding A E., Morgan-Hughes J A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988 331 717-719
20. Horvath R, Hudson G, Ferrari G et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006 129 1674-1684
21. Hudson G, Deschauer M, Busse K et al. Sensory ataxic neuropathy due to a novel C 10Orf2 mutation with probable germline mosaicism. Neurology 2005 64 371-373
22. Karpati G. The Kearns-Sayre-Shy syndrome. Vinken PJ, Bruyn GW Handbook of Clinical Neurology Amsterdam Elsevier 1979 Vol. 38 221-232
23. Kearns T P., Sayre G P. Retinitis pigmentosa, external ophthalmoplegia and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 1958 60 280-289
24. Laforet P, Lombes A, Eymard B et al. Chronic progressive external ophthalmoplegia with ragged-red fibers: clinical, morphological and genetic investigations in 43 patients. Neuromusc Disord 1995 5 399-413
25. Lou H C., Reske-Nielsen E. Progessive external ophthalmoplegia: evidence for a disorder in pyruvate-lactate metabolism. Arch Neurol 1976 33 455-456
26. Olson W, Engel W K., Walsh G O. et al. Oculocraniosomatic neuromuscular disease with ragged-red fibers. Arch Neurol 1972 26 193-211
27. Rowland L P. Molecular genetics, pseudogenetics and clinical neurology. Neurology 1983 33 1179-1195
28. Shapira Y et al. Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci 1977 13 161-164
29. Shoffner J M., Lott M T., Lezza A M. et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990 61 931-937
30. Tyynismaa H, Ylikallio E, Patel M et al. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple Deletions. Am J Hum Genet 2009 85 290-295
31. Wabbels B, Ali N, Kunz W S. et al. Chronisch-progressive externe Ophthalmoplegie und Kearns-Sayre-Syndrom. Interdisziplinäre Diagnostik und Therapie. Ophthalmologe 2008 105 550-556
32. Wallace D C., Singh G, Lott M T. et al. Mitochondrial DNA mutation associated with Leberss hereditary optic neuropathy. Science 1988 242 1427-1430
33. Yamashita S, Nishino I, Nonaka I et al. Genotype and phaenotype analyses in 136 patients with single large scale mitochondrial DNA deletions. J Hum Genet 2008 53 598-606
34. Zierz S, Wersebe O von, Gerbitz K et al. Ophthalmoplegia-plus: klinische Variabilität, biochemische Defekte der mitochondrialen Atmungskette und Deletionen des mitochondrialen Genoms. Nervenarzt 1990 61 332-339
35. Zintz R, Villiger W. Electron microscopic findings in 3 cases of chronic progressive ocular muscular dystrophy. Ophthalmologica 1967 153 439-459